Who
J. Kermit Anderson
Director
Company insider
Files Form 4 as: Director, Adial Pharmaceuticals.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Mar 2020
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,185 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,185 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 23 May 2023filed 25 May 2023 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 23 Feb 2022filed 25 Feb 2022 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 8 Feb 2021filed 10 Feb 2021 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 3 Mar 2020filed 5 Mar 2020 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.